MAZE
Maze Therapeutics, Inc.
NASDAQ · USHealthcareBiotechnology
$28.29+0.60%
Price as of Jul 20, 2026
MAZE earnings
Maze Therapeutics, Inc. earnings
Reported EPS and revenue history, upcoming estimates and available earnings-call summaries.
Next earnings
Aug 11, 2026in NaN days
EPS est $-0.76 · Revenue est $3M
Track record
Beat EPS in 2 of 4 quarters
Avg surprise -1038.5% (last 4 quarters)
Earnings history
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| May 12, 2026 | $-0.43 | $-0.45 | -4.7% | $20M | +88.2% |
| Mar 25, 2026 | $-0.73 | $-0.65 | +11.0% | — | — |
| Nov 6, 2025 | $-0.74 | $-0.66 | +10.8% | — | — |
| Mar 31, 2025 | $0.45 | $-18.32 | -4171.1% | — | — |
| Sep 30, 2024 | — | $-0.57 | — | $3M | — |
| Jun 30, 2024 | — | $3.18 | — | $165M | — |
| Mar 31, 2024 | — | $-0.74 | — | — | — |
| Dec 31, 2023 | — | $-0.61 | — | — | — |
| Sep 30, 2023 | — | $-0.57 | — | — | — |
Earnings history is derived from company filings and calendar data. Call summaries are grouped by reporting period. Latest covered event: 2026-08-11.